Facetten
Zugriff
Einrichtung
Medientyp
- Text 6
Karte
Erscheinungsjahr
Autor/in
- Quach, Hang
- Facon, Thierry 4
- Bahlis, Nizar 3
- Basu, Supratik 3
- Goldschmidt, Hartmut 3
- alle zeigen
Sprache
- Englisch 6
6 Einträge gefunden
-
Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma
- Facon, Thierry
- Kumar, Shaji K
- Plesner, Torben
- Orlowski, Robert Z
- Moreau, Philippe
- Bahlis, Nizar
- Basu, Supratik
-
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy
- Quach, Hang
- Nooka, Ajay
- Samoylova, Olga
- Venner, Christopher P
- Kim, Kihyun
- Facon, Thierry
- Spencer, Andrew
-
Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design
- Nooka, Ajay K
- Weisel, Katja
- van de Donk, Niels Wcj
- Routledge, David
- Otero, Paula Rodriguez
- Song, Kevin
- Quach, Hang
-
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
- Facon, Thierry
- Kumar, Shaji K
- Plesner, Torben
- Orlowski, Robert Z
- Moreau, Philippe
- Bahlis, Nizar
- Basu, Supratik
-
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study
- Dimopoulos, Meletios
- Quach, Hang
- Mateos, Maria-Victoria
- Landgren, Ola
- Leleu, Xavier
- Siegel, David
- Weisel, Katja
-
Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
- Facon, Thierry
- Kumar, Shaji
- Plesner, Torben
- Orlowski, Robert Z
- Moreau, Philippe
- Bahlis, Nizar
- Basu, Supratik